close

Medications

Medications

A few opioid tablets prescribed to patients discharged from emergency rooms can relieve pain while preventing abuse.

A big part of patients released from the crisis division need just five tablets or less of morphine 5mg or an identical narcotic pain reliever, as per a new examination introduced at the European Crisis Medication Congress. The new emergency in narcotic maltreatment has been partly credited to over-medicine, especially for persistent agony, and specialists have become careful about giving these medications to patients. Notwithstanding, analysts say it is fundamental that patients are given adequate drugs to assist them with recuperating from agony and injury, and the new review will assist crisis medicine specialists to get the equilibrium right. The
Medications

Antipsychotic medications are likely overprescribed to homebound dementia patients, according to a new study.

A new examination distributed in the Diary of the American Geriatrics Society shows that antipsychotics are possibly overprescribed and utilized improperly among patients with Alzheimer's disease and related dementias (ADRD) getting home medical services, and such use is connected to more awful results. Antipsychotic drugs are not supported for the treatment of dementia; they are generally utilized off-mark to deal with the side effects that many individuals with ADRD experience, like disturbance, animosity, and psychosis, which are classified as "social and mental side effects of dementia. What's more, antipsychotics convey impressive dangers of serious medication-related antagonistic occasions, particularly stroke and
Medications

Deprescribing attempts are failing dementia sufferers, according to a new study.

Scientists driven by the Beth Israel Deaconess Clinical Center, Boston, have analyzed what a dementia determination means for prescription use designs in more established adults. In a paper, "Changes in the Utilization of Long-Hour Meds Following Episode Dementia Determination," distributed in JAMA Inside Medication, a huge companion concentrate on uncovered a few surprising discoveries, including expanded general drug use soon after an occurrence dementia conclusion. Regardless of the perceived significance of working on drug regimens and lessening the risk of unfavorable medication events in people with dementia, the investigation discovered that prescribing rules and endeavors are not really executed at
Medications

Warfarin use should not preclude stroke patients from receiving life-saving clot-removal surgery, according to a new study.

According to a new study from UT Southwestern Medical Center, the majority of stroke patients taking the anticoagulant warfarin were no more likely than those not taking the medication to have a brain bleed during a procedure to remove a blood clot. The discoveries, distributed in JAMA, could assist doctors with better measuring the risk of endovascular thrombectomy (EVT), possibly extending the pool of qualified patients for this pillar stroke treatment. "Warfarin is a type of blood thinner that is frequently prescribed to patients with heart conditions like atrial fibrillation to prevent strokes. Albeit not extremely normal, patients taking warfarin
Medications

A clinical trial has identified a possible new therapy for liver illness.

Scientists at the College of California San Diego Institute of Medication have driven a review to inspect a potential new treatment choice for patients with non-alcoholic steatohepatitis (NASH)-related fibrosis. A drug that mimics a hormone in the body improved both liver fibrosis, or scarring of the liver, and liver inflammation in patients with NASH, according to the findings, which were published in the online edition of The New England Journal of Medicine on June 24, 2023. According to Rohit Loomba, MD, the study's first author and chief of the Division of Gastroenterology and Hepatology at UC San Diego School of
Medications

A medication that dramatically decreases bacteria’s potential to build antibiotic resistance has been identified in a study.

In their search for solutions to the global issue of bacterial antibiotic resistance, which was the cause of nearly 1.3 million deaths in 2019, a group of researchers at Baylor College of Medicine is gaining ground. In a paper published in Science Advances, the team describes a drug that significantly reduces bacteria's capacity to develop antibiotic resistance in animal models and laboratory cultures, potentially extending antibiotic effectiveness. Dequalinium chloride (DEQ) is a proof-of-concept drug that slows evolution. According to Dr. Susan M. Rosenberg, who holds the Ben F. Love Chair in Cancer Research and is a Baylor professor of molecular
Medications

Cancer medications have promise in the fight against malaria.

A group of UCF researchers is looking to use cancer drugs to speed up the development of new malaria treatments that can save lives as the disease becomes increasingly resistant to drugs. Debopam Chakrabarti, a molecular parasitologist at UCF, and Ratna Chakrabarti, a cancer molecular biologist, are working on a study with Nathanael Gray, a Stanford University co-leader of the cancer therapeutics research program, and Elizabeth Winzeler, a malaria drug development expert at the University of California, San Diego, to test cancer drugs for their ability to combat malaria. The ACS Infectious Diseases journal published their most recent findings. One
Medications

Q&A: Researchers identify new, more effective possibilities for syphilis therapy

Rates of sexually transmitted infections have been rising since 2000. There are few effective treatment options for syphilis, which was nearly eradicated in the United States at the time and now affects over 18 million people annually worldwide. The inability to culture and investigate the agent that causes syphilis in a laboratory setting has been one obstacle that has hampered researchers studying the disease for decades. "A reliable system for propagating the disease-causing agent in vitro or in a laboratory setting was produced through the incredible efforts of our colleagues and collaborators. According to Brandon Jutras, the project's principal investigator,
Medications

Ketamine is at least as effective as electroconvulsive therapy in treating serious depression, according to a study

Another review driven by specialists from Mass General Brigham has found that subanesthetic intravenous ketamine was powerful and not substandard compared to electroconvulsive treatment (ECT) for the treatment of non-crazy, treatment-safe misery. The New England Journal of Medicine contains their findings. Amit Anand, MD, professor of psychiatry at Harvard Medical School and director of Psychiatry Translational Clinical Trials at Mass General Brigham, stated, "ECT has been the gold standard for treating severe depression for over 80 years." Be that as it may, it is likewise a dubious treatment since it can cause cognitive decline, requires sedation, and is related to
Medications

Investigating why Indigenous ‘Spirit medicine’ ideas should be prioritized in psychedelic research.

In the highlands of Chiapas, Mexico, Yuria Celidwen was born into a family of Indigenous mystics, healers, poets, and explorers. Celdiwen, a native of Nahua and Mayan descent, stated, "I grew up with one foot in the wilderness and another in the magical realism of Indigenous culture." My childhood was filled with the stories and songs of my elders. They helped me develop my emotional intuition and mythic imagination, which served as the foundation on which the seeds of kindness, play, and wonder germinated. "But  we convey intergenerational injury and, furthermore, intergenerational rapture," she added. A consequence of the Native